Sign in →

Test Code LABICRESP Immunocompromised Respiratory Panel

Clinical Information

Detection from respiratory specimens: Adenovirus, Coronavirus (serotypes HKU1, NL63, 229E, OC43), SARS-CoV-2, Human metapneumovirus, Human rhinovirus/enterovirus, Influenza A (H1, H1-2009, H3), Influenza B, Parainfluenza virus (serotypes 1-4), Respiratory syncytial virus (RSV), Bordetella pertussis, Bordetella parapertussis, Chlamydia pneumoniae, Mycoplasma pneumoniae.

Synonym

  • ICRESP
  • BioFire RP2.1

Profile Information

Reporting Name Available Separately Always Reported
Influenza A No Yes
Influenza B No Yes
RSV No Yes
Parainfluenza 1 No Yes
Parainfluenza 2 No Yes
Parainfluenza 3 No Yes
Parainfluenza 4 No Yes
Metapneumovirus No Yes
Rhinovirus/Enterovirus No Yes
Adenovirus No Yes
Coronavirus 229E No Yes
Coronavirus NL63 No Yes
Coronavirus HKU1 No Yes
Coronavirus OC43 No Yes
Bordetella paraertussis No Yes
Bordetella pertussis No Yes
Chlamydia pneumoniae No Yes
Mycoplasma pneumoniae No Yes
Influenza A Subtype H1 No Yes
Influenza A Subtype H3 No Yes
Influenza A Subtype 2009 H1N1 No Yes
SARS-COV-2 No Yes

Specimen Required

Preferred Container/Tube: Viral Transport Media (VTM)
Acceptable Container/Tube: Viral Transport Media (VTM)
Specimen Source: Nasopharyngeal
 

Preferred Container/Tube: Sterile Container
Acceptable Container/Tube: Sterile Container
Specimen Source: BAL
Specimen Minimum Volume: 1 mL

 

Preferred Container/Tube: Sterile Container
Acceptable Container/Tube: Sterile Container
Specimen Source: CSF
Specimen Minimum Volume: 0.5 mL

Specimen Stability Information

Ambient: 4 hours
Refrigerated: 3 days

Reference Values

Not Detected (for all targets)

Interpretation

Nasopharyngeal Source
Results should be used in conjunction with other clinical and laboratory findings. This result does not rule out co-infections with pathogens that are not screened for by the Respiratory Panel(RP). This RP assay was performed using a Film Array multiplex nucleic acid assay.

 

BAL Source
Results should not be used in conjunction with other clinical and laboratory findings. This result does not rule out co-infections with pathogens that are not screened for by the Respiratory Panel(RP). This RP assay was performed using a Film Array multiplex nucleic acid assay. This test was developed and its performance characteristics determined by The Clinical Microbiology Laboratory at The Ohio State University Wexner Medical Center. It has not been cleared or approved by the FDA. The laboratory is required under CLIA as qualified to perform high-complexity testing. This test is used for clinical purposes. It should not be regarded as investigational or for research.

Cautions

This test is not a test of cure. 

Method Description

Multiplex polymerase chain reaction (PCR)

Performing Lab

Clinical Lab University East

Day(s) Performed

Monday through Sunday

Report Available

Same day/1 day

Reporting Name

Immunocompromised Respiratory Panel

CPT Code Information

NP
0202U 

 

BAL
87633
87798 x2
87486
87581

LOINC Code Information

34487-9
49521-8
49524-2 
55465-9
40982-1
29908-1
29909-9 
29910-7
41010-0
67820-1
40991-2 
82163-7
82162-9
82161-1
82164-5
40988-8
40976-3
29723-4
23826-1
34645-2
29257-3
94309-2